After withdrawing from Title X, reproductive health clinics scramble for cash

At reproductive health care providers across the country, many leaders say they were faced with an impossible choice as recipients of grants from Title X, the federal family planning program that provides affordable birth control.

They could follow a new Trump administration rule, announced in February, that bars Title X grantees from referring patients to abortion providers, a provision they say would severely compromise the care they offer.

Or they could refuse to comply, giving up millions of dollars in annual funds that pay for reproductive services for millions of women for everything from pregnancy tests to cervical cancer screenings.

For Planned Parenthood — which serves 40 percent of Title X patients — the decision was clear. On Monday, the last day to agree to the rule, the organization announced it was withdrawing from Title X rather than abiding by what it called an “unethical gag rule.”